Navigation Links
Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO)
Date:1/12/2009

Primary Businesses

-- Cataract Surgery/IOL: Devices for cataract surgery, which replaces a patient's aging and cloudy natural lens with an IOL or artificial lens to restore vision.

-- Laser Vision Correction (LASIK): Devices used for refractive laser eye surgery to correct myopia (nearsightedness), hyper-opia (farsightedness) and astigmatism (condition that causes blurred vision).

-- Eye Care: Contact lens care products including multi-purpose cleaning and disinfecting solutions, daily cleaners and contact lens rewetting drops; and over-the-counter dry eye products.

Products

-- Cataract Surgery/IOL: WhiteStar Signature(TM) Phacoemulsification System, Healon(R) Viscoelastics, Tecnis(R) Aspheric IOL, Tecnis(R) Multifocal IOL, ReZoom(R) Multifocal IOL, Verisyse(R) Phakic IOL.

-- Laser Vision Correction (LASIK): iLASIK(TM), VISX(TM) Excimer Technology, IntraLase(TM) FS Technology, Advanced CustomVue(TM) Procedure.

-- Eye Care: COMPLETE(R) Multi-Purpose Solution, Blink Contacts(TM) Lubricant Eye Drops, Oxysept(R) UltraCare Formula, Blink(R) Tears Lubricating Eye Drops

Vision Facts

-- About 60 percent of people 60+ years old have cataracts.

-- The global population is aging at unprecedented levels. There are more than 700 million people globally older than 60 (up from 600 million in 2000); by 2020, this number is projected to increase to 1 billion.

-- Cataracts are the leading cause of vision loss among people 55 and older.

-- More than 15 million cataract procedures are performed worldwide annually.

-- Approximately 52 percent of people have some form of myopia or hyperopia.

More than 3.5 million LASIK procedures are performed globally annually; LASIK accounts for more than 90 percent of all U.S. refractive surgical procedures.


'/>"/>
SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Abbott Announces Earnings Guidance for 2009
2. Webcast Alert: Isis Pharmaceuticals Announces That Abbott Exercised Its Option to Acquire Ibis Biosciences
3. Abbott Exercises Its Option to Acquire Ibis Biosciences, a Subsidiary of Isis
4. Abbotts XIENCE V(TM) Drug Eluting Stent Wins Prestigious Chicago Innovation Award
5. Abbott Hosts Conference Call for Third-Quarter Earnings
6. Abbott to Present at UBS Best of Americas Investment Conference
7. Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology
8. Abbott and AstraZeneca Expand Relationship to Include Co-Promotion of CRESTOR(R)
9. Abbott Begins Post-Approval Study of XIENCE V(TM) Drug Eluting Stent
10. FDA Approves Abbotts XIENCE(TM) V Drug Eluting Stent
11. Abbott Invests Additional $20M in Isis Subsidiary Ibis Biosciences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...swire/ -- The Appignani Bioethics Center, a projec...el discussion today at the National Press Club to ...medical sciences and climate change. The topics we...h of the Center for American Progress, who conside... ,, A video of the event will be made available...
(Date:11/9/2009)...cro cap and small cap equities across the board, a...nd exposure as a ,buying window, opens and to take...s like gold, silver and other metals," states Herb...tan based investor relations firm with a focus on ... US and Canada, and with expansion plans into the ...
(Date:11/9/2009)...-FirstCall/ -- Yongye International, Inc.,(Nasdaq:...ufacturer, developer,and distributor of Shengmings...People,s Republic of China (PRC), today announced ...m. Eastern Time (11:00 p.m. Beijing Time) on Monda...arter ended September 30, 2009. , To part...
(Date:11/9/2009)...all/ -- BioMed Realty Trust, Inc. (NYSE: BMR ) an...ments from lenders to increase the borrowing capac... to an aggregate of $665 million, with no other ch...average effective interest rate of the unsecured l...The maturity date remains August 1, 2011, which ma...
Breaking Biology Technology:Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 2Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 3Haft Group says Bullish Commodity Market Triggers Small and Micro-cap Upsurge 2Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 2Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 3BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 2BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 3
...nc. (OTC Bulletin Board: CBAI), the umbilical cord....cordblood-america.com ) focused on bringing,the l...ionwide and,internationally, today said Pennsylvan... law designed to educate pregnant women about the .... The bill was signed by Governor,Edward G. Rendel...
...s from Shire,Pharmaceuticals, Cardinal Health, 3M,...rs will address new talent development and managem...titive economy at the 10th,Annual Human Resources ...ng & Retaining Top Talent, sponsored by Best Pract... 2008, at The Ritz-Carlton Hotel, Sarasota,Fla., ...
...ibility, PRINCETON, N.J., April 10 Pharmacopeia,...d development of novel,small molecule therapeutics... resigned as President and Chief Executive Officer...o pursue other interests. His resignation was,effe...hairman of the Board, will assume day-to-day,leade...
Other Biology Technology:Cord Blood America Says Pennsylvania Joins New York and California in Establishing Educational Programs on the Benefits of Umbilical Cord Blood Storage 2Pharmaceuticals & Biotechs to Share Insights for Developing Leaders in a Fast-Paced, Competitive Industry 2Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc. 2Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc. 3Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc. 4
(Date:11/9/2009)...VEGAS, Nov. 9 CBS Vision, the rese... OMD, an Omnicom Media Group company, today announ...,s clients access to the CBS Television City resea...Vegas. ,, The new venture, which marries the c... leading agencies, will be called Communications ...
(Date:11/9/2009)... conducted in California and elsewhere provide sup...managing fisheries and protecting marine habitats,...fornia, Santa Cruz. , A recent study in the Gul...ty of a key concept behind marine reserves--the id... replenish the stocks of harvested species outside...
(Date:11/9/2009)...anol production method that begins by soaking corn...e gallons of ethanol and more usable co-products, ...uck by about 20 percent. , "The conventional et... than distillers dried grains with soluble, it doe...of Illinois Agricultural Engineer Esha Khullar. "W...
Breaking Biology News(10 mins):CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 2CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 3CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 4Studies show marine reserves can be an effective tool for managing fisheries 2Studies show marine reserves can be an effective tool for managing fisheries 3Studies show marine reserves can be an effective tool for managing fisheries 4Studies show marine reserves can be an effective tool for managing fisheries 5Wet ethanol production process yields more ethanol and more co-products 2Advancement Made in Automatic Autism Screen Increases Accuracy to 91 25 Scheduled for Release This Month 13802 1Advancement Made in Automatic Autism Screen Increases Accuracy to 91 25 Scheduled for Release This Month 13802 2Advancement Made in Automatic Autism Screen Increases Accuracy to 91 25 Scheduled for Release This Month 13802 3Sinovac Announces Supply Agreement with Boryung Pharmaceutical Company Limited in South Korea 56013 1Sinovac Announces Supply Agreement with Boryung Pharmaceutical Company Limited in South Korea 56013 2Sinovac Announces Supply Agreement with Boryung Pharmaceutical Company Limited in South Korea 56013 3Sharing Miracles Television Program to Feature Award Winning Hollywood Star Danny Glover 56010 1Sharing Miracles Television Program to Feature Award Winning Hollywood Star Danny Glover 56010 2Sharing Miracles Television Program to Feature Award Winning Hollywood Star Danny Glover 56010 3Sharing Miracles Television Program to Feature Award Winning Hollywood Star Danny Glover 56010 4Sharing Miracles Television Program to Feature Award Winning Hollywood Star Danny Glover 56010 5Sharing Miracles Television Program to Feature Award Winning Hollywood Star Danny Glover 56010 6Sharing Miracles Television Program to Feature Award Winning Hollywood Star Danny Glover 56010 7
...nteract the greenhouse effect, some scientists hav...--as it is emitted from power plants, then liquefy...here are pitfalls in that plan. , The carbon diox...bles and vent to the atmosphere, defeating the pur... liquid-to-gas conversion happens suddenly, the ga...
...international collaboration effort in Mongolia to ... vaccineAvian influenza virus samples collected fr...rom the New York City-based Wildlife Conservation ...th Organization to be part of a new human pandemic... samples, collected in the midst of an outbreak in...
... of Rochester Medical Center have targeted a new c...s in diseases such as Alzheimer,s and dementia ass...sue of The Journal of Clinical Investigation, the ...hich brain cells can be damaged during chronic neu...in the brain, nerve impulses that are passed betwe...
Other Biology News:Asleep in the deep: Model helps assess ocean-injection strategy for combating greenhouse effect 2Wild birds help to create human flu vaccine 2Wild birds help to create human flu vaccine 3Scientists show how thinking can harm brain cells 2Scientists show how thinking can harm brain cells 3
Anti-Human sVCAM-1 / CD106 ELI-PAIR Kit Antibody, Unconjugated from Cell Sciences
Mouse Anti-HNF-1 Monoclonal Antibody, Unconjugated, Clone 2 from BD Biosciences Pharmingen
Mouse Anti-GLP-1 Monoclonal Antibody, Unconjugated, Clone HYB 147-12 from Santa Cruz Biotechnology, Inc.
Baculovirus system service from Abgent
Biology Products: